Prescient Therapeutics Limited (ASX:PTX)

Prescient Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	6.91	10.49	5.9	12.26	16.1
Short-Term Investments	0.02	4.02	16.02	0.02	0.02
Cash & Short-Term Investments	6.93	14.51	21.92	12.28	16.12
Cash Growth	-52.27%	-33.78%	78.41%	-23.79%	118.48%
Accounts Receivable	4.91	3.92	2.58	1.72	1.24
Receivables	4.91	3.92	2.58	1.72	1.24
Prepaid Expenses	1.06	0.31	0.25	0.24	0.24
Total Current Assets	12.9	18.74	24.74	14.25	17.6
Property, Plant & Equipment	0.01	0	0	0	0
Other Intangible Assets	1.65	1.65	3.37	3.37	3.37
Total Assets	14.56	20.39	28.11	17.62	20.97
Accounts Payable	3.04	1.72	1.78	0.51	0.23
Accrued Expenses	0.07	0.22	0.2	0.12	0.07
Short-Term Debt	-	0.33	-	-	0.17
Other Current Liabilities	0.05	0.05	0.05	0.18	0.04
Total Current Liabilities	3.16	2.32	2.03	0.81	0.51
Pension & Post-Retirement Benefits	0.01	0.01	0.01	0.05	0.03
Total Liabilities	3.17	2.33	2.03	0.86	0.54
Common Stock	93.89	93.27	93.25	77.26	76.67
Retained Earnings	-84.07	-77.4	-69.31	-62.45	-57.51
Comprehensive Income & Other	1.57	2.19	2.14	1.95	1.26
Shareholders' Equity	11.39	18.07	26.08	16.76	20.43
Total Liabilities & Equity	14.56	20.39	28.11	17.62	20.97
Total Debt	-	0.33	-	-	0.17
Net Cash (Debt)	6.93	14.18	21.92	12.28	15.95
Net Cash Growth	-51.16%	-35.28%	78.41%	-22.99%	120.93%
Net Cash Per Share	0.01	0.02	0.03	0.02	0.03
Filing Date Shares Outstanding	805.32	805.32	805.27	654.32	641.05
Total Common Shares Outstanding	805.32	805.32	805.27	654.32	641.05
Working Capital	9.74	16.42	22.71	13.44	17.08
Book Value Per Share	0.01	0.02	0.03	0.03	0.03
Tangible Book Value	9.74	16.42	22.71	13.4	17.06
Tangible Book Value Per Share	0.01	0.02	0.03	0.02	0.03

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.